Patent · US Active

Nucleic acids encoding anti-Factor P antibodies

US10865237B2 · kind B2 · utility

0Cited by

16References

11Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Leslie Ngozi Anuna Johnson · Revere, US
Ute Jaeger · Munich, DE
Yong-In Kim · Westborough, US
Christian Carsten Silvester KUNZ · Munich, DE
Igor Splawski · Winchester, US
Michael Roguska · Cambridge, US
Joy Ghosh · Boston, US
Barbara Brannetti · Basel, CH
Michael Stefanidakis · Brookline, US
Sha LIAO · Lexington, US

Key dates

Filing date	May 7, 2018
Grant date	Dec 15, 2020
Priority date	—
Expiry date	Aug 22, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to antibodies or antigen binding fragments thereof that bind to complement Factor P and used thereof as well as combinations of anti-Factor P antibodies with antibodies or antigen binding fragments thereof that bind to complement component 5 (C5).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.